chemotherapeutic agents Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 1 (1)

Interventional (1)

Shanghai Jiao Tong University School of Medicine (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadvascular endothelial growth factor receptor 2

I am/have/hadchemoradiotherapy

I am/have/hadsquamous cell carcinoma of the head and neck

I am/have/hadvascular endothelial growth factor

I am/have/hadhead and neck squamous cell carcinoma

I am/have/hadlymph node metastases

I am/have/hadneovascularization

I am/have/hadtumor growth

I am/have/hadvegf

I am/have/hadhypoxia

I am/have/hadwhite blood cell count

I am/have/hadimmunosuppression

I am/have/hadrenal function

I am/have/hadmetastasis

I am/have/hadtumor angiogenesis

I am/have/hadsquamous cell carcinoma

I am/have/hadtargeted therapy

I am/have/hadleukocyte count

I am/have/hadcancer

I am/have/hadangiogenesis

added new label for I am/have/had

more

I am looking for

I am looking forvegf

I am looking forcamrelizumab

I am looking forapatinib

I am looking forgrowth factor

I am looking forimmune checkpoint inhibitor

I am looking forvascular endothelial growth factor

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Dental/Oral Health
Recruiting

Inductive Camrelizumab and Apatinib for Patients With Locally Advanced and Resectable Oral Squamous Cell Carcinoma

The use of targeted therapy against VEGF can not only inhibit tumor neovascularization, but also make the effectiveness of chemotherapeutic agents. VEGF and VEGFR are closely related to immune escape. Tumor growth requires new blood vessels to supply nutrients and oxygen, and VEGF can stimulate neovascularization.

vascular endothelial growth factor receptor 2

squamous cell carcinoma of the head and neck

chemoradiotherapy

vascular endothelial growth factor

head and neck squamous cell carcinoma

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.